The Efficacy and Safety of Magnesium Alloy Screw as a Novel Bioabsorbable Material in Patients Due to Hand Fractures

September 14, 2015 updated by: U&I Corporation

A Prospective, Single Center, Single Group, Open-label Study to Evaluate the Efficacy and Safety of Magnesium Alloy Screw as a Novel Bioabsorbable Material in Patients Requiring Internal Fixation Due to Hand Fractures

This study evaluates the safety and efficacy of biodegradable magnesium alloy screw, in patients with hand fractures who require internal fixation (to obtain a product license from the Ministry of Food and Drug Safety in Korea (MFDS)).

Study Overview

Status

Completed

Conditions

Detailed Description

Rationale: Hand fractures including intra- and extra-articular phalanges and metacarpal are common and account for approximately 40% of upper extremity fractures and lead to functional loss of the hand.Fractures can be treated conservatively with a nonsurgical approach(Closed reduction) by placing the damaged figure in a splint; this may results in displacement, rotation, angulation and/or instability, therefore require surgery. Surgical techniques for treatment of hand fractures include internal fixation with metal plate or screws after Open reduction and external fixation with insertion of percutaneous pins or screws. Percutaneous external fixation is one of the widely used methods, but is difficult to maintained when accompanied by unstable fractures and soft tissue injuries or there are severely comminuted fractures and sometimes results in restricted motion of adjacent joints due to prolonged fixation. In comparison, internal fixation is an operation using internal fixators such as plates, wires, screws etc. solely or concurrently depending on the location and severity of hand fracture. With the recent advancement of implant design and fixation techniques, a variety of screws are widely used for fixation of small-bone fractures.

The present study was designed to evaluate the efficacy and safety of magnesium alloy screw as a novel bioabsorbable and biodegradable material.

Study Duration: After an approval of clinical protocol from MFDS in Korea, total 20 months were required including 14 months for subject enrollment and 6 months of follow-up. An additional 1 month was required after completion of the study for handling of data, statistical analysis and preparation of study report.

Target Subjects: Patients who require internal fixation using screws due to hand fractures

Investigational Device: K-MET™ Bioresorbable Bone screw (manufactured by U&I) This device divided into two type,Cortex screw and Headless compression screw.

Number of Subjects: A total of 34 cases of bone fractures in 28 subjects.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Phase 2

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male or female patients aged 20 years or older
  • Patients who require internal fixation using screws in the hand
  • The clinical features of hand fractures are oblique and spiral fractures
  • Patients who voluntarily submitted a written informed consent and are willing to and able to follow the clinical study protocol.

Exclusion Criteria:

  • Infections around the fracture site or soft-tissue injury greater than Grade III
  • Fracture patterns such as open, transverse or comminuted fracture with greater than type II
  • Fractures that require the use of wires, pins or plates for fixation
  • Patients with re-fracture
  • Patients with critical systemic diseases
  • Patients with renal failure showing plasma creatinine level exceed 1.4 at the screening
  • Pregnant, lactating women
  • Patients who have a history of allergy to magnesium alloy
  • Patients with presence of past illness or taking a drug that may affect bone union
  • Patients who have participated in other clinical study and treated with medication or other medical device within past 3 months
  • Patients who are judged not to be appropriate for study enrollment in the opinion of the investigator

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: K-MET™ Bioresorbable Bone screw
The K-MET™ Bioresorbable Bone Screw, intended to be used for trauma therapy, consists of Cortex screws, Cannulated headless screws. For Headless screw and Cannulated headless screws, the design is similar to normal headless compression screws but the compression function was achieved by using different lengths for the front and rear pitches. These screws are dynamic and allow therewith the fracture at the Carpal, metacarpal, and small hand bone.
The biodegradable screw inserted into bone with an appropriate driver is slowly degraded and is completely degraded after completion of bone union and absorbed into the body. The screw is indicated for fixing damaged bone.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone union
Time Frame: up to 6 months
Bone union was evaluated at 6-month after surgery according to the following definition.Definition of bone union is when simple X-ray findings reveal that bone trabeculae or cortical bone exceeds the fracture site. Non-union is defined as no union at 3-month post-surgery.
up to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PROM(Passive Range of Motion)
Time Frame: up to 6 months
This Passive Range of Motion(PROM) is measured by goniometer and is compared with the value of the normal hand that did not undergo surgery.
up to 6 months
TAM(Total Active Motion)
Time Frame: up to 6 months
Total Active Motion(TAM) is measured by goniometer and is compared with the value of the normal hand that did not undergo surgery.
up to 6 months
Power(grip strength and pick-up power)
Time Frame: up to 6 months
The Power was measured using a dynamometer and pick-up counter and is compared with the value of the hand that did not undergo surgery.
up to 6 months
DASH scale
Time Frame: 3,6 months
This questionnaire evaluates the ability of the hand to perform certain activities before and after surgery. It was directly completed by subjects.
3,6 months
Pain as measured by the NRS (1~10)
Time Frame: up to 6 months
The NRS (1~10) was used to measure the level of pain and was compared before and after surgery.
up to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Gyeong-jin Han, professor, Ajou Univ hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2013

Primary Completion (Actual)

November 1, 2014

Study Completion (Actual)

December 1, 2014

Study Registration Dates

First Submitted

May 15, 2015

First Submitted That Met QC Criteria

May 25, 2015

First Posted (Estimate)

May 28, 2015

Study Record Updates

Last Update Posted (Estimate)

September 15, 2015

Last Update Submitted That Met QC Criteria

September 14, 2015

Last Verified

May 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UNI-01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hand Fractures

3
Subscribe